sábado, 8 de abril de 2023

Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17 - PubMed

Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17 - PubMed

No hay comentarios:

Publicar un comentario